Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Safety and Efficacy of HS-IT201 Injection in the Treatment of Advanced Solid Tumors

NCT06613152 is registered in ClinicalTrials.gov with Qingdao Sino-Cell Biomedicine Co., Ltd. as lead sponsor.

NCT NCT06613152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06613152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Safety and Efficacy of HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Lead sponsor
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
October 31, 2028
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor